Diagnosis and Management of Poor Neonatal Adaptation Syndrome in Newborns Exposed In Utero to Selective Seretonin/Norepinephrine Reuptake Inhibitors

Journal of Obstetrics and Gynaecology Canada

Volumn 31, Issue 4, 2009, Pages 348-350

  Koren, Gideon ^a   Finkelstein, Yaron ^a   Matsui, Doreen ^b   Berkovich, Matitiahu ^c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Depression; Neonate; Selective serotonine reuptake inhibitors; Withdrawal; Withdrawal syndrome

Indexed keywords

PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADAPTATION SYNDROME; ARTICLE; BODY TEMPERATURE; BREAST FEEDING; BREATHING RATE; CONGENITAL HEART MALFORMATION; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL DIAGNOSIS; DRUG BLOOD LEVEL; DRUG SAFETY; ELECTROCARDIOGRAM; HUMAN; INSOMNIA; IRRITABILITY; LENGTH OF STAY; LONG TERM EXPOSURE; NEONATAL STRESS; OXYGEN SATURATION; PNEUMOTHORAX; PRENATAL DRUG EXPOSURE; PULMONARY ASPIRATION; PULSE RATE; QT PROLONGATION; RESPIRATORY DISTRESS; RIGIDITY; SEIZURE; TRANSIENT TACHYPNEA OF THE NEWBORN; TREMOR; WEAKNESS; DEPRESSION; FEMALE; FETOMATERNAL TRANSFUSION; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; WITHDRAWAL SYNDROME;

DEPRESSION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS;

EID: 68049111363     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34157-3     Document Type: Article

References (16)

1. Koren G., Matsui D., Einarson A., Knoppert D., Steiner M. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?. CMAJ 2005, 172:1457-1459.
2. van Geffen E.C., Hugtenburg J.G., Heerdink E.R., van Hulten R.P., Egberts A.C. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation. Eur J Clin Pharmacol 2005, 61:303-307.
3. de Moor R.A., Mourad L., ter Haar J., Egberts A.C. Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy. Ned Tijdschr Geneeskd 2003, 147:1370-1372.
4. Tomaselli G., Modestin J. Repetition of serotonin syndrome after reexpousre to SSRI-a case report. Pharmacopsychiatry 2004, 37:236-238.
5. Knoppert D.C., Nimkar R., Principi T., Yuen D. Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels. Ther Drug Monit 2006, 28:5-7.
6. Dubnov R., Koren G., Finkelstein Y. Prolonged QT Interval in Neonates Exposed to Selective Serotonin Reuptake Inhibitors in Late Pregnancy. Clin Pharmacol Ther 2008, 83:S42.
7. Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004, 158:307-308.
8. Coupland N.J., Bell C.J., Potokar J.P. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996, 16:356-362.
9. Koren G., Moretti M., Kapur B. Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome. J Obstet Gynaecol Can 2006, 28:299-302.
10. Einarson A., Kahan M., Ordean A., Tschokovsky K., Wood W. Exposure to psychotropic medications and other substances during pregnancy and lactation 2007, Centre for Addiction and Mental Health, Toronto.
11. Krantz I., Eriksson B., Lundquist-Persson C., Ahlberg B.M., Nilstun T. Screening for postpartum depression with the Edinburgh Postnatal Depression Scale (EPDS): an ethical analysis. Scand J Public Health 2008, 36:211-216.
12. Finnegan L.P., Connaughton J.F., Kron R.E., Emich J.P. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975, 2:141-158.
13. Levinson-Castiel R., Merlob P., Linder N., Sirota L., Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006, 160:173-176.
14. Lynskey M.T., Agrawal A., Bucholz K.K., Nelson E.C., Madden P.A., Todorov A.A., Grant J.D., Martin N.G., Health A.C. Subtypes of illicit drug users: a latent class analysis of data from an Australian twin sample. Twin Res Hum Genet 2006, 9:523-530.
15. Koren G., Hutson J., Gareri J. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Clin Pharmacol Ther 2008, 83:631-634.
16. Theis J.G., Selby P., Ikizler Y., Koren G. Current management of the neonatal abstinence syndrome: a critical analysis of the evidence. Biol Neonate 1997, 71:345-356.